ArticleDaru : journal of Faculty of Pharmacy, Tehran University of Medical Sciences2013
Trend analysis of the pharmaceutical market in Iran; 1997-2010; policy implications for developing countries.
Article in Daru : journal of Faculty of Pharmacy, Tehran University of Medical Sciences, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 40 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
40 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Assessment of the Effects of Economic Sanctions on Iranians' Right to Health by Using Human Rights Impact Assessment Tool: A Systematic Review.International journal of health policy and management · 2018Pooled it
- Application of Freire's adult education model in modifying the psychological constructs of health belief model in self-medication behaviors of older adults: a randomized controlled trial.BMC public health · 2020Trial
- Uses of private health provider data for governance in low-income and middle-income countries: results from a scoping review.BMJ open · 2024Article
- The experiences and perceptions of people with chronic and rare diseases during political-economic sanctions in Iran: a qualitative study.BMC health services research · 2024Article
- Out-of-pocket pharmaceutical expenditure and its determinants among Iranian households with elderly members: a double-hurdle model.Cost effectiveness and resource allocation : C/E · 2024Article
- Economic barriers and gaps to reach the desirable consumption of salt, sugar, and fat in Iran: a qualitative study.Journal of health, population, and nutrition · 2023Article
- Factors Affecting the Product Life Cycle of Generic Medicines.Iranian journal of pharmaceutical research : IJPR · 2022Article
- Pharmaceutical subsidy policy in Iran: a qualitative stakeholder analysis.Health research policy and systems · 2021Article
- Environmental risk assessments of multiclass pharmaceutical active compounds: selection of high priority concern pharmaceuticals using entropy-utility functions.Environmental science and pollution research international · 2021Article
- The Impact of Inflation and Its Uncertainty on Pharmaceutical Prices: Evidence from Iran.Iranian journal of pharmaceutical research : IJPR · 2021Article
- Assessment of Influential Variables in the Pricing of Locally Manufactured Pharmaceuticals: Current Challenging Situation in Iran.Iranian journal of pharmaceutical research : IJPR · 2021Article
- Short and long term impacts of COVID-19 on the pharmaceutical sector.Daru : journal of Faculty of Pharmacy, Tehran University of Medical Sciences · 2020Article
- The impact of sanction and healthcare system reform on the healthcare performance and pharmaceutical market in Iran; 2001-2016.Journal of pharmaceutical policy and practice · 2020Article
- Life After Myocardial Infarction: A Qualitative Study on Experiences of Kurdish Patients Affected by Iran-Iraq War.Patient related outcome measures · 2020Article
- Policies to improve access to pharmaceutical products in shortage: the experience of Iran food and drug administration.Daru : journal of Faculty of Pharmacy, Tehran University of Medical Sciences · 2019Article
- The Study of Effective Factors on Iran's Pharmaceutical Export Supply and Demand.Iranian journal of pharmaceutical research : IJPR · 2019Article
- The Structure of the World Pharmaceutical Market: Prioritizing Iran's Target Export Markets.Iranian journal of pharmaceutical research : IJPR · 2019Article
- Policy Analysis Of Iranian Pharmaceutical Sector; A Qualitative Study.Risk management and healthcare policy · 2019Article
- Optimization of rPDT fusion protein expression by Escherichia coli in pilot scale fermentation: a statistical experimental design approach.AMB Express · 2018Article
- Trends in Iran Pharmaceutical Market.Iranian journal of pharmaceutical research : IJPR · 2017Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundSo far, no detailed study of the Iranian pharmaceutical market has been conducted, and only a few studies have analyzed medicine consumption and expenditure in Iran. Pharmaceutical market trend analysis remains one of the most useful instruments to evaluate the pharmaceutical systems efficiency. An increase in imports of medicines, and a simultaneous decrease in domestic production prompted us to investigate the pharmaceutical expenditure structure. On the other hand, analyzing statistics provides a suitable method to assess the outcomes of national pharmaceutical policies and regulations.
methodsThis is a descriptive and cross-sectional study which investigates the Iranian pharmaceutical market over a 13-year period (1997-2010). This study used the Iranian pharmaceutical statistical datasheet published by the Iranian Ministry of Health. Systematic searches of the relevant Persian and English research literature were made. In addition, official government documents were analyzed as sources of both data and detailed statements of policy.
resultsAnalysis of the Iranian pharmaceutical market in the 13-year period shows that medicine consumption sales value growth has been 28.38% annually. Determination of domestic production and import reveals that 9.3% and 42.3% annual growth, respectively, have been experienced.
conclusionsThe Iranian pharmaceutical market has undergone great growth in comparison with developing countries and the pharmerging group, and the market is expanding quickly while a major share goes to biotechnology drugs, which implies the need to commercialization activities in novel fields like pharmaceutical biotechnology. This market expansion has been in favor of imported medicine in sales terms, caused by the reinforcement of suspicious policies of policy makers that necessitates fundamental rearrangements.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.